Integrative analysis of aberrant Wnt signaling in hepatitis B virus-related hepatocellular carcinoma

doi:10.3748/wjg.v21.i20.6317

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 21, Issue 20

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (10791)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-9) series.

Item

Count

PDF

670

WORD

194

HTML

6731

Figures (1-3)

218

Tables (1-9)

196

Sum=8009

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1045

Download

1737

Sum=2782

May 28, 2015 (publication date) through Nov 22, 2024

Times Cited of This Article

Times Cited (27)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Systematic Reviews

World J Gastroenterol. May 28, 2015; 21(20): 6317-6328
Published online May 28, 2015. doi: 10.3748/wjg.v21.i20.6317

Table 1 CTNNB1 mutation case resources in each article

PubMed ID	Total cases	HBV infection cases	HCV infection cases	HBV and HCV coinfection cases	Non-viral infection cases
9635572	14/75	NA/NA	NA/NA	NA/NA	NA/NA
9671767	8/31	NA/NA	NA/NA	NA/NA	NA/NA
10487827	14/32	2/5	2/13	0/0	10/13
10595907	13/22	0/0	13/22	0/0	0/0
10665646	9/38	NA/NA	NA/NA	NA/NA	NA/NA
10700176	13/100	NA/NA	NA/NA	NA/NA	NA/NA
10980116	57/421	27/265	23/95	3/44	4/17
11282485	6/32	NA/NA	NA/NA	NA/NA	NA/NA
11375957	26/137	3/33	12/31	0/9	11/41
11429783	0/22	0/0	0/0	0/0	0/22
11443619	7/60	5/48	0/2	0/0	2/10
11477549	1/14	0/1	1/12	0/0	0/1
11570580	15/34	NA/NA	NA/NA	NA/NA	NA/NA
12101426	14/73	NA/NA	NA/NA	NA/NA	NA/NA
12375019	10/57	0/0	10/57	0/0	0/0
12439747	184/1123	NA/NA	NA/NA	NA/NA	NA/NA
12845670	24/100	5/26	16/51	0/0	3/23
14999698	3/61	0/29	0/7	0/1	0/0
15067328	10/89	NA/NA	NA/NA	NA/NA	NA/NA
15151624	1/61	NA/NA	NA/NA	NA/NA	NA/NA
15288479	2/16	0/0	0/4	0/0	2/6
15305374	44/781	NA/512	NA/151	NA/52	NA/66
15814635	37/265	NA/161	NA/53	NA/26	NA/25
17187432	34/120	NA/NA	NA/NA	NA/NA	NA/NA
17393110	7/29	NA/NA	NA/NA	NA/NA	NA/NA
17510384	13/81	2/13	8/44	1/2	2/18
17531558	4/42	0/7	4/23	0/3	0/9
18171349	1/36	0/21	0/4	0/0	1/11
18282277	11/52	NA/NA	NA/NA	NA/NA	NA/NA
18358501	4/54	3/43	0/1	0/2	1/8
18467159	47/223	NA/NA	NA/NA	NA/NA	NA/NA
18701503	28/81	0/0	28/81	0/0	0/0
19101982	10/32	0/0	3/6	0/0	7/26
20347502	1/1	0/0	1/1	0/0	0/0
20923573	7/15	1/4	4/10	0/0	2/2
20963515	2/20	2/20	0/0	0/0	0/0
21457159	19/44	3/11	10/23	1/2	5/8
21822264	28/139	5/50	13/43	1/2	9/44
22561517	42/149	3/32	7/24	1/4	31/89
25021421	53/176	13/78	NA/NA	NA/NA	NA/NA

Data are presented as the number of mutation cases/category total. HBV: Hepatitis B virus; HCV: Hepatitis C virus; NA: Not available.

Table 2 AXIN1 mutation case resources in each article

PubMed ID	Total cases	HBV infection cases	HCV infection cases	HBV and HCV coinfection cases	Non-viral infection cases
10700176	9/100	NA/NA	NA/NA	NA/NA	NA/NA
11375957	12/112	8/32	0/31	2/9	2/40
12101426	4/56	0/9	0/5	0/2	4/40
15067328	25/89	NA/NA	NA/NA	NA/NA	NA/NA
18171349	9/36	5/21	3/4	0/0	1/11
21499249	1/1	0/0	1/1	0/0	0/0
22561517	19/149	5/32	5/24	1/4	8/89
25021421	25/176	13/78	NA/NA	NA/NA	NA/NA

Data are presented as the number of mutation cases/category total. HBV: Hepatitis B virus; HCV: Hepatitis C virus; NA: Not available.

Table 3 TP53 mutation case resources in each article

PubMed ID	Total cases	HBV infection cases	HCV infection cases	HBV and HCV coinfection cases	Non-viral infection cases
1311638	0/21/36	0/21/36	0/0/0	0/0/0	0/0/0
1327523	3/20/61	3/12/37	0/4/17	0/3/4	0/1/3
1655254	2/9/43	NA/NA/NA	NA/NA/NA	NA/NA/NA	NA/NA/NA
1672732	0/5/10	0/5/8	0/0/NA	0/0/NA	0/0/NA
1849234	0/8/16	NA/NA/NA	NA/NA/NA	NA/NA/NA	NA/NA/NA
7903205	2/20/35	2/15/28	0/NA/NA	0/NA/NA	0/NA/NA
8093350	1/17/53	0/3/7	NA/NA/NA	NA/NA/NA	NA/NA/NA
8093978	0/3/20	0/NA/17	0/NA/NA	0/NA/NA	0/NA/NA
8100480	1/3/20	NA/NA/NA	NA/NA/NA	NA/NA/NA	NA/NA/NA
8108145	2/6/15	2/6/15	0/0/0	0/0/0	0/0/0
8261444	5/12/16	1/2/3	4/8/10	0/1/2	0/1/1
8290606	0/19/80	0/8/28	0/NA/NA	0/NA/NA	0/NA/NA
8302580	1/6/22	NA/NA/NA	NA/NA/NA	NA/NA/NA	NA/NA/NA
8380058	0/2/15	0/NA/NA	0/NA/NA	0/NA/NA	0/NA/NA
8382111	0/12/38	0/NA/NA	0/NA/NA	0/NA/NA	0/NA/NA
8384081	0/4/45	0/4/28	0/0/11	0/0/2	0/0/4
8389246	0/11/34	0/NA/NA	0/NA/NA	0/NA/NA	0/NA/NA
8390289	0/10/15	0/8/13	0/NA/NA	0/NA/NA	0/NA/NA
8390407	0/1/18	0/0/3	0/0/5	0/0/1	0/1/9
8393166	1/1/7	NA/NA/NA	NA/NA/NA	NA/NA/NA	NA/NA/NA
8407553	3/19/63	2/10/16	1/4/15	0/0/0	0/5/32
8565124	0/2/12	0/0/3	0/0/2	0/0/1	0/2/6
8655704	3/10/38	NA/NA/19	NA/NA/10	NA/NA/5	NA/NA/4
8655958	2/2/20	1/1/4	NA/NA/NA	NA/NA/NA	NA/NA/NA
8672994	0/1/18	0/NA/NA	0/NA/NA	0/NA/NA	0/NA/NA
8895490	0/9/12	0/0/0	0/1/3	0/2/3	0/3/6
9012469	0/8/16	0/1/8	0/NA/NA	0/NA/NA	0/NA/NA
9270015	2/26/105	2/24/78	0/NA/NA	0/NA/NA	0/NA/NA
9463584	0/2/8	0/NA/NA	0/NA/NA	0/NA/NA	0/NA/NA
9699537	2/6/97	NA/NA/16	NA/NA/NA	NA/NA/NA	NA/NA/NA
9781942	1/2/15	0/0/0	1/2/15	0/0/0	0/0/0
10389750	0/17/31	0/11/17	0/NA/NA	0/NA/NA	0/NA/NA
10389978	0/12/24	0/10/19	0/NA/NA	0/NA/NA	0/NA/NA
10564952	2/9/11	NA/NA/NA	NA/NA/NA	NA/NA/NA	NA/NA/NA
10662591	0/5/27	NA/NA/NA	NA/NA/NA	NA/NA/NA	NA/NA/NA
10699891	4/11/18	0/0/0	0/0/0	0/0/0	4/11/18
10743047	0/35/40	0/33/38	0/NA/NA	0/NA/NA	0/NA/NA
11051249	2/21/83	0/14/50	1/6/16	0/0/0	1/1/17
11191353	0/14/55	0/NA/45	0/NA/NA	0/NA/NA	0/NA/NA
11282486	2/6/22	NA/NA/NA	NA/NA/NA	NA/NA/NA	NA/NA/NA
11375957	1/36/137	1/15/33	0/10/31	0/3/9	0/8/41
11704835	8/30/71	NA/NA/NA	NA/NA/NA	NA/NA/NA	NA/NA/NA
12483005	3/7/34	2/5/27	0/1/3	0/0/0	1/1/4
12640682	0/2/18	0/1/5	0/1/8	0/0/4	0/0/1
12759240	2/16/33	2/16/33	0/0/0	0/0/0	0/0/0
12845670	0/14/100	0/4/26	0/7/51	0/0/0	0/3/23
14499690	0/18/68	0/NA/52	0/NA/2	0/0/0	0/NA/14
14675778	0/5/22	0/0/0	0/5/22	0/0/0	0/0/0
14687797	3/9/80	2/7/NA	0/1/NA	0/0/NA	1/1/NA
15017592	4/22/50	NA/NA/13	NA/NA/33	NA/NA/3	NA/NA/1
15126338	3/27/48	NA/NA/NA	NA/NA/NA	NA/NA/NA	NA/NA/NA
15943041	8/8/20	8/8/20	0/0/0	0/0/0	0/0/0
16078640	2/7/41	NA/NA/1	NA/NA/26	NA/NA/NA	NA/NA/NA
16570275	1/11/40	1/4/22	0/2/5	0/2/5	0/3/8
16685387	0/28/55	0/NA/49	0/NA/NA	0/NA/NA	0/NA/NA
16697535	0/7/23	0/7/23	0/0/0	0/0/0	0/0/0
17066440	0/5/51	0/0/14	0/4/30	0/0/0	0/1/7
17266182	1/28/50	1/24/41	0/NA/NA	0/NA/NA	0/NA/NA
17350822	4/16/83	NA/2/13	NA/13/64	NA/0/2	NA/1/4
17510384	0/25/81	0/5/13	0/15/44	0/2/2	0/3/18
17531558	2/7/42	1/1/7	1/4/24	0/1/2	0/1/9
21499249	0/1/1	0/0/0	0/1/1	0/0/0	0/0/0
21760996	0/9/26	0/6/13	0/2/4	0/0/0	0/0/4
21822264	4/39/139	2/20/50	1/10/43	0/2/2	1/7/44
22561517	0/26/149	0/9/32	0/7/24	0/2/4	0/8/89
22634756	3/14/27	3/7/11	0/7/14	0/0/0	0/0/2
22922871	1/1/10	1/1/10	0/0/0	0/0/0	0/0/0

Data are presented as the number of gain-of-function mutation cases/number of mutations/category total. HBV: Hepatitis B virus; HCV: Hepatitis C virus; NA: Not available.

Table 4 Mutation case numbers and rates of CTNNB1 in different tissues

Cancer type	Mutation cases (n)	Total cases (n)	Mutation rate (%)	P value¹
HCC	671	3720	18.04
Colon Adenocarcinoma	126	1318	9.56	< 0.001
Ovary carcinoma	102	1599	6.38	< 0.001
Stomach Adenocarcinoma	54	1137	4.75	< 0.001
Lung Adenocarcinoma	38	1219	3.12	< 0.001
ESCC	5	347	1.44	< 0.001

¹The P value vs HCC. ESCC: Esophageal squamous cell carcinoma; HCC: Hepatocellular carcinoma.

Table 5 Mutation case numbers and rates of CTNNB1 in hepatocellular carcinoma etiologies

Viral background	Mutation cases (n)	Total cases (n)	Mutation rate (%)	P value¹
HBV	74	686	10.79
HCV	155	554	27.98	< 0.001
HBV and HCV	7	69	10.14	0.999
Non-viral	90	348	25.86	< 0.001

¹The P value vs HBV. HBV: Hepatitis B virus; HCV: Hepatitis C virus.

Table 6 Mutation case numbers and rates of AXIN1 in different tissues

Cancer type	Mutation cases (n)	Total cases (n)	Mutation rate (%)
Hepatocellular carcinoma	75	872	8.60
Colon adenocarcinoma	20	513	3.90
Ovary carcinoma	3	749	0.40
Stomach adenocarcinoma	18	377	4.77
Lung adenocarcinoma	6	697	0.86
Esophageal squamous cell carcinoma	3	130	2.31

Table 7 Mutation case numbers and rates of AXIN1 in hepatocellular carcinoma etiologies

Viral background	Mutation cases (n)	Total cases (n)	Mutation rate (%)	P value¹
HBV	31	172	18.02
HCV	9	65	13.85	0.964
HBV and HCV	3	15	20.00	0.999
non-viral	15	180	8.33	0.122

¹The P value vs HBV. HBV: Hepatitis B virus; HCV: Hepatitis C virus.

Table 8 Mutation case numbers and rates of TP53 in different tissues

Cancer type	GOF mutation cases (n)	Mutation cases (n)	Total cases (n)	GOF mutation rate (%)	Non-GOF mutation rate (%)	Total mutation rate (%)	P value¹
HCC	91	825	2813	3.23	26.09	29.33
Colon adenocarcinoma	331	1867	3596	9.20	42.71	51.92	< 0.001
Ovary carcinoma	392	1604	3329	11.78	36.41	48.18	< 0.001
Stomach adenocarcinoma	270	1160	3459	7.81	25.73	33.54	< 0.001
Lung adenocarcinoma	421	2414	6394	6.58	31.17	37.75	< 0.001
ESCC	224	972	1858	12.06	40.26	52.31	< 0.001

¹GOF mutation rate vs HCC. ESCC: Esophageal squamous cell carcinoma; GOF: Gain-of-function; HCC: Hepatocellular carcinoma.

Table 9 Mutation case numbers and rates of TP53 in hepatocellular carcinoma etiologies

Viral background	GOF mutation cases (n)	Mutation cases (n)	Total cases (n)	GOF mutation rate (%)	Non-GOF mutation rate (%)	Total mutation rate (%)
HBV	35	321	819	4.27	34.92	39.19
HCV	9	101	398	2.26	23.12	25.38
HBV and HCV	0	18	41	0.00	43.90	43.90
non-viral	7	60	346	2.02	15.32	17.34

GOF: Gain-of-function; HBV: Hepatitis B virus; HCV: Hepatitis C virus.

Citation: Ding SL, Yang ZW, Wang J, Zhang XL, Chen XM, Lu FM. Integrative analysis of aberrant Wnt signaling in hepatitis B virus-related hepatocellular carcinoma. World J Gastroenterol 2015; 21(20): 6317-6328
URL: https://www.wjgnet.com/1007-9327/full/v21/i20/6317.htm
DOI: https://dx.doi.org/10.3748/wjg.v21.i20.6317